...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
【24h】

Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.

机译:经皮十四烷基硫酸钠硬化剂治疗周围静脉血管畸形:单中心经验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose To evaluate the efficacy, safety, and long-term outcomes of percutaneous sodium tetradecyl sulfate (STS) sclerotherapy for peripheral venous vascular malformations (VVMs). Materials and Methods A retrospective review of a prospectively compiled database was performed to identify patients with a VVM who were referred from 1997 to 2004. Of the 132 patients identified, 78 underwent sclerotherapy. Six of the 78 patients were lost to follow-up. Of the remaining 72 patients (24 male and 48 female patients; mean age, 31.7 years; age range, 14-62 years), 42 (58%) had lower limb VVMs, 19 (26%) had upper limb VVMs, and nine (12%) had truncal and/or central VVMs. Two patients (2.8%) had multifocal lesions. Seven of the 72 patients (9.7%) had Klippel-Trenauney syndrome. Treatment response was assessed clinically and by means of lesion size measurement with magnetic resonance (MR) imaging. Results A total of 226 treatment sessions were performed (mean, 3.1 sessions per patient; range, 1-13 sessions). The mean follow-up was 41 months (range, 21-84 months). After treatment, 11 patients (15%) became asymptomatic, 20 (28%) rated the response to therapy as good, 17 (24%) improved, 20 (28%) were unchanged, and four (5.6%) worsened. Thirty-five patients underwent MR imaging before and after treatment. The size of the VVM was seen to decrease in 19 patients (54%), be unchanged in 11 (31%), and increase in five (14%). A reduction in lesion size at MR imaging did not necessarily correlate with a positive clinical response. Overall, patients with infiltrative lesions had a poorer outcome than did those with localized lesions. There were no major complications and seven minor complications (3.1% per session, 9.7% per patient). Conclusions An improvement in symptoms was observed in 70% of the patients with VVMs treated with percutaneous STS. Although the treatment is safe, complete cure is unusual and multiple treatment sessions are almost always required.
机译:目的评估经皮十四烷基硫酸钠(STS)硬化疗法治疗周围静脉血管畸形(VVM)的疗效,安全性和长期效果。资料和方法对前瞻性汇编数据库进行回顾性研究,以鉴定1997年至2004年转诊的VVM患者。在确定的132例患者中,有78例接受了硬化治疗。 78名患者中有6名失去了随访。在其余的72位患者中(24位男性和48位女性患者;平均年龄31.7岁;年龄范围14-62岁),其中42位(58%)有下肢VVM,19位(26%)有上肢VVM,还有9位(12%)有截头和/或中央VVM。 2例(2.8%)有多灶性病变。 72名患者中有7名(9.7%)患有Klippel-Trenauney综合征。临床评估治疗效果,并通过磁共振(MR)成像测量病变大小。结果总共进行了226次治疗(平均每名患者3.1次;范围1-13次)。平均随访41个月(范围21-84个月)。治疗后,11例患者(15%)无症状,20例(28%)对治疗的反应良好,17例(24%)改善,20例(28%)不变,4例(5.6%)恶化。 35例患者在治疗前后接受了MR成像。 VVM的大小在19例患者中减少了(54%),在11例中没有变化(31%),在5例中增加了(14%)。 MR成像中病变大小的减少不一定与阳性临床反应相关。总体而言,浸润性病变的患者预后较局部病变的患者差。没有大的并发症和七个小并发症(每节3.1%,每名患者9.7%)。结论经皮STS治疗的VVM患者中有70%的症状得到改善。尽管治疗安全,但完全治愈并不常见,几乎总是需要多次治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号